{"id":714438,"date":"2022-11-22T16:38:00","date_gmt":"2022-11-22T21:38:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/"},"modified":"2022-11-22T16:38:00","modified_gmt":"2022-11-22T21:38:00","slug":"kronos-bio-announces-participation-in-upcoming-investor-conferences-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/","title":{"rendered":"Kronos Bio Announces Participation in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov.  22, 2022  (GLOBE NEWSWIRE) &#8212; Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">Piper Sandler\u2019s 34th Annual Healthcare Conference on Tuesday, November 29, 2022, at 11:30 a.m. ET; and<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">Evercore ISI\u2019s 5th Annual HealthCONx on Thursday, December 1, 2022, at 1 p.m. ET.<\/li>\n<\/ul>\n<p align=\"justify\">The fireside chats will be available on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6_aDsdxiIIMlHMTtaspw4AyLAcUgcL1ps0icnL9XV9n5UBZKddx4aAt7-RNz8zpOHHWZhuOkdIBoK1ADpA3bPMG54BjSOhctmpgPXkvVaigOrGi3WALyKeS9k-XXVFU3\" rel=\"nofollow noopener\" target=\"_blank\">Investors &amp; Media<\/a> section of the company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZvzVGlfHQEJi8TSRVrouuvcssmvvedtt3EsyLjW4Zd8lEG8c5miAOBmqdJ6YOa97Kv3nbwU4qXpb2A09a5EGJg==\" rel=\"nofollow noopener\" target=\"_blank\">www.kronosbio.com<\/a>. A replay of the webcasts will be archived and available for one month following each event.<\/p>\n<p align=\"justify\">\n        <strong>About Kronos Bio, Inc.<br \/><\/strong>Kronos Bio is a biopharmaceutical company that is advancing two investigational compounds in clinical trials for patients with cancer. The company is developing the CDK9 inhibitor, KB-0742, as a treatment for <em>MYC<\/em>-amplified solid tumors, and lanraplenib, a next-generation SYK inhibitor, for patients with relapsed\/refractory FLT3-mutated acute myeloid leukemia. The company\u2019s scientific focus is on developing medicines that target the dysregulated transcription that is the hallmark of cancer and other serious diseases.<\/p>\n<p align=\"justify\">Kronos Bio is based in San Mateo, Calif., and has a research facility in Cambridge, Mass. For more information, visit www.kronosbio.com or follow the company on LinkedIn.<\/p>\n<p>\n        <strong>Company contact:<br \/><\/strong>Marni Kottle<br \/>Kronos Bio<br \/>650-900-3450<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XoAZkSwhUWEMPCbBToJqLhLRJJRXGX7v9o05aJZkQEilBKkglkBRxcl199NJfxUlcPYCz3LrMYEXtTVGcIzqg0pChgNrtAAHj8T0CRBFm7A=\" rel=\"nofollow noopener\" target=\"_blank\">mkottle@kronosbio.com<\/a>\u00a0<\/p>\n<p>\n        <strong>Investors:<br \/><\/strong>Claudia Styslinger<br \/>Argot Partners<br \/>212-600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d8RTJvYQu0-9SgbaA3zVXwM8v6htylNc6wvRTrHtkRYzp2naM6QXSHYyTBIimg8KxMltvUYmHo2Lacw_-IZDTFN4lwxbRt3iF0YHhIFrJHYgs2TG2f3dNHg8yiGHb-DH\" rel=\"nofollow noopener\" target=\"_blank\">kronosbio@argotpartners.com<\/a><\/p>\n<p>\n        <strong>Media:<br \/><\/strong>Sheryl Seapy<br \/>Real Chemistry<br \/>949-903-4750<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=evGh94WxWlsVAWtOkMx6xtsxcR6PAmkPhVByMUtk5Kr3UwswVISq_dneXiw_DkTgUJON5kAF9hOihM7wnjH4blRzx-37_aLDzG9rBuw7Il0=\" rel=\"nofollow noopener\" target=\"_blank\">sseapy@realchemistry.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OGVlNDA5Y2EtNWMxYi00ZjEwLWEzYTctZmZiODI2MzFhMDUzLTEyMTQ4NDY=\/tiny\/Kronos-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences: Piper Sandler\u2019s 34th Annual Healthcare Conference on Tuesday, November 29, 2022, at 11:30 a.m. ET; and Evercore ISI\u2019s 5th Annual HealthCONx on Thursday, December 1, 2022, at 1 p.m. ET. The fireside chats will be available on the\u00a0Investors &amp; Media section of the company\u2019s website at\u00a0www.kronosbio.com. A replay of the webcasts will be archived and available for one month following each event. About Kronos Bio, Inc.Kronos Bio is a biopharmaceutical company that is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kronos Bio Announces Participation in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-714438","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kronos Bio Announces Participation in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kronos Bio Announces Participation in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences: Piper Sandler\u2019s 34th Annual Healthcare Conference on Tuesday, November 29, 2022, at 11:30 a.m. ET; and Evercore ISI\u2019s 5th Annual HealthCONx on Thursday, December 1, 2022, at 1 p.m. ET. The fireside chats will be available on the\u00a0Investors &amp; Media section of the company\u2019s website at\u00a0www.kronosbio.com. A replay of the webcasts will be archived and available for one month following each event. About Kronos Bio, Inc.Kronos Bio is a biopharmaceutical company that is &hellip; Continue reading &quot;Kronos Bio Announces Participation in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T21:38:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kronos Bio Announces Participation in Upcoming Investor Conferences\",\"datePublished\":\"2022-11-22T21:38:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/\"},\"wordCount\":253,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/\",\"name\":\"Kronos Bio Announces Participation in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=\",\"datePublished\":\"2022-11-22T21:38:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kronos Bio Announces Participation in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kronos Bio Announces Participation in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/","og_locale":"en_US","og_type":"article","og_title":"Kronos Bio Announces Participation in Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) &#8212; Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences: Piper Sandler\u2019s 34th Annual Healthcare Conference on Tuesday, November 29, 2022, at 11:30 a.m. ET; and Evercore ISI\u2019s 5th Annual HealthCONx on Thursday, December 1, 2022, at 1 p.m. ET. The fireside chats will be available on the\u00a0Investors &amp; Media section of the company\u2019s website at\u00a0www.kronosbio.com. A replay of the webcasts will be archived and available for one month following each event. About Kronos Bio, Inc.Kronos Bio is a biopharmaceutical company that is &hellip; Continue reading \"Kronos Bio Announces Participation in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/","og_site_name":"Market Newsdesk","article_published_time":"2022-11-22T21:38:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kronos Bio Announces Participation in Upcoming Investor Conferences","datePublished":"2022-11-22T21:38:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/"},"wordCount":253,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/","name":"Kronos Bio Announces Participation in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=","datePublished":"2022-11-22T21:38:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjA4NiM1Mjc4NzcyIzIyMDMyOTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kronos-bio-announces-participation-in-upcoming-investor-conferences-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kronos Bio Announces Participation in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=714438"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714438\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=714438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=714438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=714438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}